Skip to main content

Advertisement

Log in

Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

This study aims to compare the clinical outcomes of a combination of enamel matrix derivatives (EMD) and a synthetic bone graft (biphasic calcium phosphate) with EMD alone in wide and deep one- and two-wall intrabony defects 36 months after treatment.

Material and methods

Thirty patients with chronic periodontitis and one wide (≥ 2 mm) and deep (≥ 4 mm) intrabony defect had been recruited in three centres in Germany. During surgery, defects were randomly assigned to EMD/synthetic bone graft (SBG) (test) or EMD (control). Assessments at baseline, after 6, 12 and 36 months, included bone sounding, relative clinical attachment levels, probing pocket depths and recessions.

Results

After 36 months, defects in both groups were significantly improved (p < 0.001) with regard to defect fill, attachment gain and probing pocket reduction. In the EMD/SBG group, a mean defect fill of 2.6 mm (±1.7) was measured, and in the EMD group, the defect fill was 2.3 mm (±1.5). A mean gain in clinical attachment of 4.1 mm (±3.6) and 3.8 mm (±2.2) was observed in the test and in the control group, respectively. There were no statistically significant differences in any of the investigated parameters between the two treatment modalities.

Conclusions

The clinical improvements of advanced intrabony defects obtained with both regenerative modalities could be maintained over a period of 3 years. The combination of EMD with SBG did not show any advantage compared to the use of EMD alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hammarström L, Heijl L, Gestrelius S (1997) Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24:669–677

    Article  PubMed  Google Scholar 

  2. Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with guided tissue regeneration and enamel-matrix-proteins. An experimental study in monkeys. J Clin Periodontol 27:466–472

    Article  PubMed  Google Scholar 

  3. Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696

    Article  PubMed  Google Scholar 

  4. Mellonig J (1999) Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restorative Dent 19:9–19

    Google Scholar 

  5. Sculean A, Donos N, Windisch P, Brecx M, Gera I, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322

    Article  PubMed  Google Scholar 

  6. Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restorative Dent 20:374–381

    PubMed  Google Scholar 

  7. Heijl L, Heden G, Svardström G, Ostgren A (1997) Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714

    Article  PubMed  Google Scholar 

  8. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 72:25–34

    Article  PubMed  Google Scholar 

  9. Tonetti MS, Fourmousis I, Suvan J, Cortellini P, Bragger U, Lang NP (2004) Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony defects. J Clin Periodontol 31:1092–1098

    Article  PubMed  Google Scholar 

  10. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. J Clin Periodontol 29:317–325

    Article  PubMed  Google Scholar 

  11. Venezia E, Goldstein M, Boyan BD, Schwartz Z (2004) The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis. Crit Rev Oral Biol Med 15:382–402

    Article  PubMed  Google Scholar 

  12. Pietruska MD (2001) A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 109:178–181

    Article  PubMed  Google Scholar 

  13. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403

    Article  PubMed  Google Scholar 

  14. Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M (2002) Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol 73:401–408

    Article  PubMed  Google Scholar 

  15. Sculean A, Chiantella GC, Windisch P, Gera I, Reich E (2002) Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restorative Dent 22:259–267

    PubMed  Google Scholar 

  16. Rosen PS, Reynolds MA (2002) A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Periodontol 73:942–949

    Article  PubMed  Google Scholar 

  17. Döri F, Arweiler N, Gera I, Sculean A (2005) Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate. J Periodontol 76:2236–2243

    Article  PubMed  Google Scholar 

  18. Trombelli L, Farina R (2008) Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration. J Clin Periodontol 35:117–135

    Article  PubMed  Google Scholar 

  19. Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71:1110–1116

    Article  PubMed  Google Scholar 

  20. Velasquez-Plata D, Scheyer ET, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 73:433–440

    Article  PubMed  Google Scholar 

  21. Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735

    Article  PubMed  Google Scholar 

  22. Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L (2007) Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78:231–238

    Article  PubMed  Google Scholar 

  23. Yilmaz S, Cakar G, Yildirim B, Sculean A (2010) Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone. J Clin Periodontol 37:544–550

    Article  PubMed  Google Scholar 

  24. Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. J Periodontol 63:729–735

    Article  PubMed  Google Scholar 

  25. Piattelli A, Scarano A, Mangano C (1996) Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials 17:1767–1770

    Article  PubMed  Google Scholar 

  26. Daculsi G, Weiss P, Bouler JM, Gauthier O, Millot F, Aguado E (1999) Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials. Bone 25:59S–61S

    Article  PubMed  Google Scholar 

  27. Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D (2007) Evaluation of a novel biphasic calcium phosphate in standardized bone defects. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Impants Res 18:752–760

    Article  Google Scholar 

  28. Stein JM, Fickl S, Yekta SS, Hoischen U, Ocklenburg C, Smeets R (2009) Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. J Periodontol 80:1774–1782

    Article  PubMed  Google Scholar 

  29. Jepsen S, Topoll H, Rengers H, Heinz B, Teich M, Hoffmann T, Al-Machot E, Meyle J, Jervøe-Storm PM (2008) Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized-controlled clinical trial. J Clin Periodontol 35:420–428

    Article  PubMed  Google Scholar 

  30. Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm PM, Meiss C, Eickholz P, Jepsen S (2011) A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. J Clin Periodontol 38:652–660

    Article  PubMed  Google Scholar 

  31. Cortellini P, Prato GP, Tonetti MS (1995) The modified papilla preservation technique. A new surgical approach for interproximal regenerative procedures. J Periodontol 66:261–266

    Article  PubMed  Google Scholar 

  32. Cortellini P, Prato GP, Tonetti MS (1999) The simplified papilla preservation flap. A novel surgical approach for the management of soft tissues in regenerative procedures. Int J Periodontics Restorative Dent 19:589–599

    PubMed  Google Scholar 

  33. Pontoriero R, Wennström JL, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840

    Article  PubMed  Google Scholar 

  34. Wachtel H, Schenk G, Bohm S, Weng D, Zuhr O, Hürzeler MB (2003) Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. J Clin Periodontol 30:496–504

    Article  PubMed  Google Scholar 

  35. Parodi R, Santarelli GA, Gasparetto B (2004) Treatment of intrabony pockets with Emdogain: results at 36 months. Int J Periodontics Restorative Dent 24:57–63

    PubMed  Google Scholar 

  36. Esposito M, Grusovin MG, Coulthard P, Worthington HV (2005) Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst Rev CD003875

  37. Francetti L, Trombelli L, Lombardo G, Guida L, Cafiero C, Roccuzzo M, Carusi G, Del Fabbro M (2005) Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study. Int J Periodontics Restorative Dent 25:461–473

    PubMed  Google Scholar 

  38. Heden G, Wennström JL (2006) Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 77:295–301

    Article  PubMed  Google Scholar 

  39. Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M (2008) Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration. J Clin Periodontol 35:817–824

    Article  PubMed  Google Scholar 

  40. Harrel SK, Wilson TG Jr, Nunn ME (2010) Prospective assessment of the use of enamel matrix derivative with minimally invasive surgery: 6-year results. J Periodontol 81:435–441

    Article  PubMed  Google Scholar 

  41. Machtei EE (1997) Outcome variables for the study of periodontal regeneration. Ann Periodontol 2:229–239

    Article  PubMed  Google Scholar 

  42. Gurinsky BS, Mills MP, Mellonig JT (2004) Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75:1309–1318

    Article  PubMed  Google Scholar 

  43. Tu YK, Woolston A, Faggion CM Jr (2010) Do bone grafts or barrier membranes provide additional treatment effects for infrabony lesions treated with enamel matrix derivatives? A network meta-analysis of randomized-controlled trials. J Clin Periodontol 37:59–79

    Article  PubMed  Google Scholar 

  44. Bokan I, Bill JS, Schlagenhauf U (2006) Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects. J Clin Periodontol 33:885–893

    Article  PubMed  Google Scholar 

  45. Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C (2007) Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 34:507–513

    Article  PubMed  Google Scholar 

  46. Pietruska M, Pieruski J, Nagy K, Brecx M, Arweiler N, Sculean A (2012) Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate. Clin Oral Investig 16:1191–1197

    Article  PubMed  Google Scholar 

  47. De Leonardis D, Paolantonio M (2013) Enamel matrix derivative, alone or associated with a synthetic bone substitute, in the treatment of 1- to 2-wall periodontal defects. J Periodontol 84:444–455

    Article  PubMed  Google Scholar 

  48. Renvert S, Badersten A, Nilvéus R, Egelberg J (1981) Healing after treatment of periodontal intraosseous defects. I. Comparative study of clinical methods. J Clin Periodontol 8:387–399

    Article  PubMed  Google Scholar 

  49. Sculean A, Windisch P, Szendroi-Kiss D, Horvath A, Rosta P, Becker J, Gera I, Schwarz F (2008) Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 79:1991–1999

    Article  PubMed  Google Scholar 

  50. Sculean A, Chiantella GC, Arweiler NB, Becker J, Schwarz F, Stavropoulos A (2008) Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral. Int J Periodontics Restorative Dent 28:153–161

    PubMed  Google Scholar 

  51. Silvestri M, Rasperini G, Milani S (2011) 120 infrabony defects treated with regenerative therapy: long-term results. J Periodontol 82:668–675

    Article  PubMed  Google Scholar 

Download references

Source of funding

The initial phase of this study (baseline to 12 months) was supported by the Institut Straumann AG, Basel, Switzerland. The 3-year follow-up was funded by the authors’ own institutions.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Søren Jepsen.

Additional information

Thomas Hoffmann and Elyan Al-Machot contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoffmann, T., Al-Machot, E., Meyle, J. et al. Three-year results following regenerative periodontal surgery of advanced intrabony defects with enamel matrix derivative alone or combined with a synthetic bone graft. Clin Oral Invest 20, 357–364 (2016). https://doi.org/10.1007/s00784-015-1522-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-015-1522-4

Keywords

Navigation